Evaluation of Breast Cancer Screening Program at Assiut Governorate
- Disease/Condition
- Breast Cancer
- Drug/Device/Intervention
- Evaluation of breast screening
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Assiut University
- Phase
- N/A
- Start date
- Jun 01, 2024
- End date
- May 30, 2025
- Enrollment
- 15000000 participants
1-To evaluate the ability of breast clinical examination as screening tool to detect early and advanced stages of breast cancer.
1. To evaluate the ability of breast clinical examination as screening tool to detect early
 and advanced stages of breast cancer.
 
 2. To determine the percentage of breast cancer confirmed cases among women screened at
 women health campaign in Assiut governorate.
 
 3. To determine drop out from referral system among screening program.
 
 4. Identify the healthcare providers knowledge about breast cancer and screening tools,
 perception, practice and barriers in delivering the program
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06403917
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06403917 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Breast Cancer. Target enrollment is 15000000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.